BPG is committed to discovery and dissemination of knowledge
Citation
Pagán B, Isidro AA, Cruz ML, Ren Y, Coppola D, Wu J, Appleyard CB. Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model. World J Gastroenterol 2011; 17(44): 4858-4866 [PMID: 22171126 DOI: 10.3748/wjg.v17.i44.4858]
Please LOGIN to submit a new comment.
Write to the Help Desk